Finanzen von LeMaitre Vascular Inc (LMAT)LMATLeMaitre Vascular Inc

Evaluating the bottom line, LeMaitre Vascular, Inc. maintains a gross margin of 72.13%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 28.98%, while the net margin is 24.22%. These profitability ratios, combined with a Return on Equity (ROE) of 16.77%, provide a clear picture of how effectively LMAT converts its operational activities into shareholder value.

In the context of the broader market, LMAT competes directly with industry leaders such as BLFS and INSP. With a market capitalization of $1.88B, it holds a leading position in the sector. When comparing efficiency, LMAT's gross margin of 72.13% stands against BLFS's 63.69% and INSP's 85.48%. Such benchmarking helps identify whether LeMaitre Vascular, Inc. is trading at a premium or discount relative to its financial performance.

LeMaitre has shown strong revenue growth, with Q2 2026 revenue at $70.38 million and a gross margin of 72.13%. However, the company has revised its full-year revenue guidance down to $276.3 million, reflecting challenges in meeting expectations.